November 6, 2024

Kamala Harris and Donald Trump offer, at least on face value, very different economic platforms, with different investment opportunities. Here’s a general guide on where to consider buying in or cashing out, based on their general policies. Note: This article is provided for informational purposes only and should not be construed as financial advice. The […]

Paul Sanger interviewed Damian Spring, CEO of Santana Minerals Limited (ASX:SMI), to discuss the Bendigo gold project, which has recently been designated as a fast-track project. Damian highlighted the project’s economic potential, projecting 1.1 million ounces of gold over ten years, which could generate significant export earnings and job creation in New Zealand. He mentioned

Domain Holdings Australia (ASX:DHG) provided a positive trading update during its 2024 Annual General Meeting, held today, reporting steady revenue growth driven by demand in its digital and premium listing segments. For the first quarter of FY25, Domain’s residential revenue grew by 12% year-on-year, with depth revenue rising by 15% and digital revenue up by

Neuren Pharmaceuticals (ASX:NEU) is set to receive a substantial payout following the sale of a Rare Pediatric Disease Priority Review Voucher (PRV) by its US-based partner, Acadia Pharmaceuticals (NASDAQ: ACAD), for $US150m. Under the agreement, Neuren will receive one-third of the net proceeds, estimated to be approximately $US50m.  The PRV was issued by the US

Apple may soon be hit with the first major fine under the European Union’s Digital Markets Act (DMA), marking a critical moment in the EU’s fight to curb Big Tech’s monopolistic practices. The European Commission is preparing to penalise Apple over its App Store policies. Sources suggest the decision, expected this month, could see Apple